from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1302/rfe

LFCtreatmentdescriptionclass of inhibitor

-1.024

Amikacinug/mL Amikacintranslation

-0.539

Cap5-10ug/mL Capreomycintranslation

0.069

Rox10-50 ug/mL Roxithromycintranslation

0.004

SM2-5 ug/mL Streptomycintranslation

-1.986

Tet5-10 ug/mL Tetracyclinetranslation

0.162

Rif0.2-5ug/mL Rifampicintranscription

-0.244

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.662

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.055

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.097

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.685

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.131

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.107

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.425

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.253

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.137

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.560

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.114

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.116

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.009

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.591

KCN5-20 ug/mL Potassium cyaniderespiration

-0.812

NaN30.2-2 mM Sodium aziderespiration

0.159

Nigericin50 uM Nigericinrespiration

-0.135

TRC10-150 ug/mL Triclosanrespiration

0.206

TRZ10-25 ug/mL Thioridazinerespiration

-0.990

Valinomycin0.5-10 uM Valinomycinrespiration

-0.456

ZnSO42 mM ZnSO4respiration

-1.080

menadione6-10 ug/mL Menadionerespiration

-0.499

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.277

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.768

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.679

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.746

NRP_1Non-replicating persistence stage 1dosRassociated

0.240

Amp0.2mg/mL AmpicillincellWall

-0.269

Cephalexin20-100 ug/mL CephalexincellWall

-0.486

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.348

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.286

EMB10-20 ug/mL EthambutolcellWall

-0.359

Eta12-40 ug/mL EthionamidecellWall

-0.138

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.503

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.126

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.098

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.480

BZA0.12 mg/mL BenzamidearomaticAmides

0.418

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.861

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.719

H2O24 mM hydrogen peroxideDNAdamaging

0.624

Levo10 ug/mL LevofloxacinDNAdamaging

0.886

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.835

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.344

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.646

UVUV-irradiationDNAdamaging

0.275

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.013

Antimycin12.5-50 ug/mL Antimycin A?

0.016

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.069

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.170

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.729

PA8240.2-2 ug/mL PA-824?

-1.011

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.089

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.270

Verapamil50 uM Verapamil?

-0.103

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.458

methoxatin10-20 ug/mL Methoxatin?